Products for Research Use Only
RegisterLogin

GLPG-1690

CAT: 0013-GTR19163946-08Size: 200 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0013-GTR19163946-08Size:200 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
GLPG-1690 (Ziritaxestat, GLPG1690) is a first-in-class, potent, competitive autotaxin inhibitor with Ki/IC50 of 15 nM/131 nM; inhibits ATX-induced LPA 18:2 production in mouse, rat, and healthy donor plasma with IC50 of 418 nM, 542 nM, and 242 nM, respectively; shows no CYP3A4 TDI and decreased hERG inhibitory activity (IC50=15 uM), and good pharmacokinetic profile for treatment idiopathic pulmonary fibrosis.Fibrosis, Phase 2 Clinical.
CAS Number
1628260-79-6
Product Name Alternative
Ziritaxestat | GLPG 1690 | GLPG1690
Purity
>98% (HPLC)
Solubility
DMSO: Soluble (< 1 mg/ml refers to the product slightly soluble or insoluble)
Smiles
CCC (N=C1N2C=C (C=C1C) N3CCN (CC3) CC (N4CC (C4) O) =O) =C2N (C) C5=NC (C6=CC=C (C=C6) F) =C (S5) C#N
Molecular Formula
C30H33FN8O2S
Molecular Weight
588.71
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
2-[[2-Ethyl-6-[4-[2- (3-hydroxyazetidin-1-yl) -2-oxoethyl]-piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]-methylamino]-4- (4-fluorophenyl) thiazole-5-carbonitrile

Chemical Information

Ziritaxestat

Ziritaxestat is under investigation in clinical trial NCT03798366 (A Clinical Study to Test How Effective and Safe GLPG1690 is for Patients With Systemic Sclerosis).

CAS Number1628260-79-6
PubChem CID90420193
IUPAC Name2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile
Molecular FormulaC30H33FN8O2S
Molecular Weight588.7
XLogP4.8
Topological Polar Surface Area132
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count10
Rotatable Bond Count7
Heavy Atom Count42
Formal Charge0
Complexity995
SMILES
CCC1=C(N2C=C(C=C(C2=N1)C)N3CCN(CC3)CC(=O)N4CC(C4)O)N(C)C5=NC(=C(S5)C#N)C6=CC=C(C=C6)F
InChI
InChI=1S/C30H33FN8O2S/c1-4-24-29(35(3)30-34-27(25(14-32)42-30)20-5-7-21(31)8-6-20)39-15-22(13-19(2)28(39)33-24)37-11-9-36(10-12-37)18-26(41)38-16-23(40)17-38/h5-8,13,15,23,40H,4,9-12,16-18H2,1-3H3
InChIKey
REQQVBGILUTQNN-UHFFFAOYSA-N
Chemical Structure
2D Structure
2D structure of Ziritaxestat
CAS: 1628260-79-6
CID: 90420193
Formula: C30H33FN8O2S
MW: 588.7
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight588.7
XLogP34.8
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count10
Rotatable Bond Count7
Exact Mass588.24312166
Monoisotopic Mass588.24312166
Topological Polar Surface Area132 Ų
Heavy Atom Count42
Formal Charge0
Complexity995
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
GTR19239759-01AK-1690
GTR19086578-01Recombinant Rhomboid protease glpG (glpG)
GTR19086575-01Recombinant Rhomboid protease glpG (glpG)
GTR19087268-01Recombinant Rhomboid protease glpG (glpG)
GTR19086574-01Recombinant Rhomboid protease glpG (glpG)
GTR19086573-01Recombinant Rhomboid protease glpG (glpG)
GTR19087257-01Recombinant Rhomboid protease glpG (glpG)
GTR19086639-01Recombinant Rhomboid protease glpG (glpG)
GTR17980058GlpG Antibody
GTR17980056GlpG Antibody

Alternative Products

CatalogName
MBS3602426-01GLPG-1690
522696Ziritaxestat (GLPG-1690)
T201032-01AK-1690
MBS7015851-01Recombinant Rhomboid protease glpG (glpG)
A24495-100AK-1690 100mg
MBS3600803-01GLPG-0492
MBS131872GLPG-1837
bs-7155C-01GLPG 0187
M11618-01GLPG 0974
MBS3601294-01GLPG-0187

Popular Products